14 Dec 2017

(1823 votes)

Cancer Treatment with Rigvir® in Australia: When Applied and Costs Involved

After going through surgery and several rounds of chemo or radiation therapy, the Australians cancer patients keep on contacting us to learn whether Rigvir® can be a suitable treatment for diseases like metastatic melanoma, pleural mesothelioma and breast cancer or not. Other inquiries often relate to the treatment duration, side effects, the Rigvir® virotherapy costs as well as care options.

We have provided the answers down below and pointed out all medical reports you need to have ready in place to qualify for Rigvir®. Let’s get straight to the point.

Here Is How Rigvir® Therapy Works And Why It Is Safe For Your Health

Discovered and researched in 1960s by the team of Aina Muceniece, a Latvian scientist and immunologist, Rigvir® has become the first oncolytic (naturally occurring virus that infects and kills cancer cells) virus-based cancer medication without being genetically modified. It proved to extend the survival of the late-stage melanoma, gastric and gastrointestinal cancerpatients from three to five years as the study said.[1]

The virus comes into collision with cancer cells by multiplying inside them and destroying the tumor from within. In such a way, it stimulates your immune system to resist the disease in a natural way. And what is more, this process does not have a negative impact on other healthy tissues.

The most common side effect caused by Rigvir® is a non-significant increase in temperature (up to 37.5°C/99.5°F), which is also good for the immune system proper functioning. It means that Rigvir® can be safely combined with chemotherapy and radiation therapy or used alone as the main treatment.

List Of Cancer Types That Are Vulnerable To Rigvir®

Since 1968, solid research has been initiated to check how other types of cancer (except for melanoma) react to Rigvir®. It was discovered that virotherapy works for:

  • Bladder cancer
  • Prostate cancer
  • Breast cancer
  • Lung cancer
  • Kidney cancer
  • Stomach cancer
  • Colon cancer
  • Different types of sarcoma
  • Ovarian cancer
  • Anal cancer
  • Cervical cancer etc.
  • Glioblastoma

Please noteRigvir® cannot be used for the treatment of the liquid malignancies like myeloma and leukemia. Similarly, there is no proof that it can be of help when dealing with glioblastoma, bone cancer, gallbladder cancer and some other tumors. And most importantly, Rigvir® must be used to treat patients above the age of 18.

Rigvir® Is Not Registered in Australia, But You Still Have Treatment Options

If you happen to search for Rigvir® on the Cancer Australia website, you will have no matches found. Being officially registered in Latvia back in 2004, the Rigvir® virotherapy medication is also approved by the state authorities of Georgia, Armenia and Uzbekistan.

But the list of countries will expand as the medication passes the standard clinical trial procedures enforced in Europe. The European Commission has funded the Rigvir® manufacturer to further introduce it to the European market by providing the Horizon 2020 grant (the program favoring research and innovation). So getting Rigvir® approved by the Australian Government may be the goal to be achieved in the long run.

Meanwhile, you still can receive the Rigvir® treatment, but in Germany.

Submit Five Medical Files to Know If You Can Receive Rigvir® Treatment in Australia

If your disease is on the list above, the next step is to collect five medical reports to qualify for the Rigvir® therapy in Germany. It may take up to one month, so you better start preparing the files as early as possible:

  • Biopsy (or pathology) report
  • Cytology report
  • CBC (complete blood count) + WBC (white blood cells) not older than 2 weeks
  • Blood biochemistry incl. ALT (alanine aminotransferase), creatinine, etc.
  • Radiology reports (actual images are not needed)

Besides, there is no need to translate the documents, since all the clinic doctors speak English fluently.

Once they receive your request, it will be examined by the board of the oncologists in the German clinic to make sure that Rigvir® is a good fit for you. Right after the decision is made, you will get a response within three business days at the latest.

Importantly: your case will be evaluated free of charge.

One-Week Inpatient Care in Germany for EUR 6,000 (AUD 9,675) Include Rigvir® Injections, Detox of Your Body, Accommodation and 24/7 Support

If the oncologists come to the conclusion that you can be eligible for the Rigvir® therapy, you may choose 7-day onsite treatment in Germany. It costs EUR 6,000, which is equal to about AUD 9,675.

Rigvir® in Australia Rigvir® in Australia Rigvir® in AustraliaRigvir® in AustraliaRigvir® in AustraliaRigvir® in Australia

Some facts about the clinic:

  1. It is located in a small town of Brannenburg, Germany. The town is surrounded by forests, and the clinic doesn’t look like a hospital — more like a countryside house.

  2. Brannenburg is 1,5-hour drive from Munich International Airport, and you don’t have to worry about transfer, as it’s included in your package.

  3. It was established by a family of oncologists, who have practiced a lot before opening the clinic in 2000. Since then, 3,000 patients have been successfully treated.

  4. Such results became possible to achieve due to combination of different therapies that have 1+1>2 effect. In addition to virotherapy, you can get:

  • Buserelin therapy that regulates reproductive hormones in prostate and breast cancer patients to help them fight the disease.

  • Needle therapy (acupuncture) to relaunch the blood flow in your organism.

  • Local hyperthermia to get rid of prostate cancer by using heat as the main instrument.

  • Detox is generally used to clean your body from accumulated toxins via highly nutritious food.

  • Gentle surgery, compared to traditional one, implies having smaller cuts and less number of them. It improves the process of recovery.

  • Naturopathic complex program is a combination of detox with physiotherapy: magnetic field therapy, lymph drainage, massage etc.

The package covers transfer expenses, daily consultations with doctors, Rigvir® injections, accommodation with all the necessary facilities and 24/7 medical care.

You may also be interested in flying from Australia to Germany. On average, it takes from 23 to 38 hours to get to Munich from the Australian airport in Melbourne with one or two stops. Using Qatar Airways means you’ll stop in Doha for 3 hours to fly directly to Munich. This ticket costs around 730 AUD if booked 3 weeks in advance.

A cheaper ticket (630 AUD) implies you’ll have 2 stops — in Guangzhou and Paris, and the flight will take 37 hours.

Rigvir® Treatment Stats and Reviews to Make Your Doubts Fade Away 

As for the cancer treatment stats, the clinical trials conducted showed that the average survival rate of the Rigvir® patients is:

  • From three to five years for melanoma patients treated with both surgery and Rigvir® (57–84% for a three-year survival rate and 44–66% for a five-year survival rate).
  • From three to five years for the patients diagnosed with eye melanoma (90% and 70% respectively).
  • The five-year post-surgery survival rate for the third-stage stomach cancer patients (47–60% patients showed such survival rate).
  • The five-year post-surgery survival rate for the stage 2-4 rectal cancer patients (proved by 71–78% of cases).

So far, you may still have a few questions about the Rigvir® package in Germany or other issues. To get answers via Skype or email, please fill in the form on the right or by clicking the button below. Once done, we will reach out to you within 24 hours. 


List of References

  1. Brūvere, R., O., Heisele A. Ferdats, A. Rupais, and A. Muceniece, Echovirus-mediated biotherapy for malignant tumours: 40 years of investigation. Acta medica Lituanica, 2002. Suppl. 9: p. 97-100.
  2. Alberts, P., E. Olmane, L. Brokāne, Z. Krastiņa, M. Romanovska, K. Kupčs, S. Isajevs, G. Proboka, R. Erdmanis, J. Nazarovs, and D. Venskus, Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports. APMIS, 2016. 124(10): p. 896-904.